Additional file 1 of Unit-to-unit transfer due to shortage of intensive care beds in Sweden 2015–2019 was associated with a lower risk of death but a longer intensive care stay compared to no transfer: a registry study

Additional file 1: Table S1. Sensitivity analyses of the odds ratio for death at 90 days in transferred patients adding different confounders to the final model 3 described in the methods section (adjusted for SAPS 3 score, primary ICD-10 ICU diagnosis and days in the ICU before transfer/no transfer). Table S2. Post-hoc comparison of transferred patients limited to non-transferred patients being present in the ICU at the time of a transfer due to lack of resources (n = 7744). Table S3. Missing data. Table S4. Number of patients with certain diagnoses as listed in the ICD10 system

Drug prescriptions and cost of drugs during 180-days PRE/POST first observed inpatient visit with ICD-10 diagnosis M79 for the anthroposophic integrative care and conventional care groups.

<p>DDD, Defined daily dose. ATC, Anatomical Therapeutic Chemical Classification System: ATC-M (Musculoskeletal system, e.g. anti-inflammatories and muscle relaxants; ATC-N02 (Analgesics); ATC-N05 (Psycholeptics). Average (95% confidence interval), p values; Analyzes by t-tests (two tailed).</p

Patient characteristics, matching and baseline values for the integrative care and conventional care groups.

<p>ICD-10, International Classification of Diseases version 10. ATC, Anatomical Therapeutic Chemical Classification System: ATC-M (Musculoskeletal system, e.g. anti-inflammatories and muscle relaxants; ATC-N02 (Analgesics); ATC-N05 (Psycholeptics). DDD, Defined daily dose. PRE, value preceding index visit. Average (95% confidence interval) values unless otherwise stated. Analyzes by t-tests (two-tailed). There were no statistically significant differences between groups at baseline.</p

Types of study designs and sample sizes.

<p>Types of study designs and sample sizes.</p

Percentage of patients with preventable adverse drug reactions among outpatients being hospitalised or visiting emergency care.

<p>*not provided directly in the study, interpreted from other presented data.</p

Classification of statistical methods as reported in journals.

<p>Classification of statistical methods as reported in journals.</p

Flow chart showing the selection process of articles and the number in each period.

<p>Flow chart showing the selection process of articles and the number in each period.</p

Characteristics of included studies on preventable adverse drug reactions among outpatients being hospitalised^φ.

<p>ADR = adverse drug reaction; WHO = World Health Organization.</p>φ<p>ADRs are present at admission and may or may not be the main reason for hospitalisation.</p>†<p>Data from study used for analyses for both outpatients and inpatients.</p><p>*ADR reason for re-hospitalisation.</p>‡<p>Studies using WHO’s definition may have referenced another publication for the definition.</p>#<p>Compared the two methods for assessing preventability of which the “own criteria” was chosen to be included in the meta-analysis.</p

Characteristics of included studies on preventable adverse drug reactions among outpatients visiting emergency care.

<p>ADR = adverse drug reaction; WHO = World Health Organization.</p>‡<p>Studies using WHO’s definition may have referenced another publication for the definition.</p

Preventability of adverse drug reactions among inpatients, during hospitalisation.

<p>*not provided directly in the study, interpreted from other presented data.</p